当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 利润表

科伦药业

(002422)

  

流通市值:233.76亿  总市值:325.68亿
流通股本:10.33亿   总股本:14.40亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312019-06-302018-12-31
一、营业总收入3,537,617,00717,636,267,0448,922,199,60116,351,790,239
营业收入3,537,617,00717,636,267,0448,922,199,60116,351,790,239
二、营业总成本3,576,356,66816,607,270,1338,229,136,24115,289,225,132
营业成本1,734,080,0827,022,556,5943,576,981,2956,612,151,970
营业税金及附加41,789,874224,935,291114,922,226229,206,598
销售费用1,007,425,8716,550,305,2253,241,122,0455,987,227,180
管理费用270,003,589951,143,512475,999,527830,412,157
财务费用197,575,462572,462,588291,361,911631,502,893
资产减值损失-7,631,837-56,325,889-17,808,091113,492,921
三、其他经营收益58,006,02242,453,2976,260,87992,909,422
允许价值变动净收益--------
投资净收益35,701,016174,046,11680,311,347146,683,035
联营、合营企业投资收益35,701,016174,046,11680,311,347146,683,035
汇兑净收益--------
四、营业利润47,879,3171,276,876,799849,195,4771,356,199,798
营业外收入291,7786,103,1072,326,222146,338,928
营业外支出15,750,72726,685,9803,406,650169,134,256
非流动资产处置净损失--------
五、利润总额32,420,3681,256,293,926848,115,0491,333,404,470
所得税1,313,044234,752,64575,421,92565,920,426
未确认的投资损失--------
六、净利润(百万元)21.89937.86728.26335.69
少数股东损益9,218,09783,686,15344,428,75654,539,795
归属于母公司股东的净利润21,889,227937,855,128728,264,3681,212,944,249
七、每股收益0.020.660.51--
基本每股收益0.020.660.510.85
稀释每股收益0.020.660.510.85
TOP↑